COATING · slippery wires: revolutionizing COronAry sTentING
„Хоризонт 2020“ — Действия „Мария Склодовска-Кюри“
- Период
- 2019-07-01 → 2021-06-30
- Финансиране от ЕС
- 203 149 €
- Участници
- 1
- Схема
- MSCA-IF
Линиите свързват координатора с партньорите.
Накратко на български
Магнитни течности (ферофлуиди) се тестват като смазка за нишките на коронарните стентове, за да се намали триенето в кръвоносните съдове. Това може да подобри качеството на живот на пациентите и да замени или допълни лекарствата с тежки странични ефекти.
Кратко обяснение, генерирано от езиков модел по текста на CORDIS. Оригиналът е по-долу.
Резултати накратко
COATING - slippery wires: revolutionizing COronAry sTentING
The present research aims to provide the foundation for the development of an alternative strategy for the inhibition of stent thrombosis and restenosis. Instead of modifying blood rheology (i.e., acting on the fluid side), it is hypothesized that a substantial reduction of the shear stress in the vessel can be achieved by modifying the properties of the vessel wall, with the aim of lubricating the stent struts, wires composing the stent structures. Specifically, the project intends to explore the potential of magnetorheological fluids (also called ferrofluids FFs), by investigating their capability in terms of drag reduction and evaluating their possible use in coronary stents. The proposed technology strives to complement or even replace adjunctive pharmacological treatments (dual antiplatelet therapy) usually adopted after stent implantation, which often have significant harmful side effects. This new technology thus has the potential to improve the quality of life of patients with stent applications, and to provide a new solution for patients in which the dual antiplatelet drug treatment cannot be prescribed. The overall objectives of the COATING projects are the following: • To evaluate the performance in terms of magnetoviscous effects of various biocompatible FFs under different shear flows and different magnetic fields. This data will be used to select the optimal FFs for drag reduction in relation to different flow regimes. • To evaluate the performance of the novel drag reduction technique based on a layer of FFs at the wall of a pipe. Results will be obtained under both laminar and turbulent flows and using different fluids, spanning the parameter range of physiological flows and beyond (e.g., Newtonian fluids with different viscosity; non Newtonian fluids with shear dependent viscosity, characteristic Re of small and large arteries, turbulent flow etc.). • To evaluate the efficiency of the FF drag reduction technique in stents in vitro. Measurements will be carried out using a blood-mimicking fluid under pulsatile flow regimes. The experimental analysis will provide an important test of the feasibility of the technique for the targeted application (stent), in view of future clinical implementation (for example, on the FF diffusion). The COATING research activities showed for the first time the relation of the magnetoviscous effect in relation to the microscopic reorganization (chain formation and disruption in flow). Moreover, it has been demonstrated that a drag reduction technique based on the adoption of ferrofluids is feasible in different flow regimes (laminar, transitional and turbulent). Experimental evidences provide results in terms of drag reduction up to 90% for flow in laminar regime. Finally, qualitative results showed the feasibility of the technique for complex geometry configuration as the one of the targeted stent application.
Текст от CORDIS, на английски · Данни: CORDIS, © Европейски съюз
Цел на проекта
COATING aims at developing cutting-edge technology for the reduction of stent thrombosis and restenosis events, based on a multidisciplinary approach linking fluid mechanics and biomedical engineering. Principles of fluid mechanics will be combined with nanotechnology to advance our understanding of the physics of drag reduction and exploit this to establish a novel biomedical engineering application. The nanotechnology is based on magnetorheological fluids, also called ferrofluids (FFs). Specifically, FFs will be used as a lubricant for the reduction of harmful wall shear stresses generated at the coronary stent surface. The objectives are, firstly, to evaluate the performance in terms of magnetoviscous effects of various biocompatible FFs varying shear and magnetic field strength. Secondly, we will evaluate the FF-based drag reduction by performing extensive FF-coated pipe flow experiments. Finally, we will evaluate the efficiency of the novel drag reduction technique in stents in vitro. The project will be hosted at WSL, Switzerland, which is part of the ETH domain, a world leading and closely cooperating network of research institutes, and will be integrated in a young and dynamic research group, offering a cutting-edge laboratory and excellent opportunities for career development.The proposed technology strives to complement or even replace adjunctive pharmacological treatments usually adopted after stent implantation, which often have significant harmful side effects. It has the potential to improve the quality of life of the millions of patients worldwide that undergo coronary stenting each year, and to provide a new solution for patients in which pharmacological therapies cannot be prescribed. Finally, the project results are also expected to foster other applications of FFs in the bio-engineering medical field and to develop a new drag reduction technology applicable in other research areas (e.g., oil pipe industries) that seek to reduce energy consumption.
Оригинален текст от CORDIS (на английски).
Участници
- EIDGENOSSISCHE FORSCHUNGSANSTALT WSL · BirmensdorfКоординаторШвейцария
Връзки
- Виж в CORDIS
- DOI: 10.3030/841259
- https://www.researchgate.net/project/COATING-Slippery-wires-revolutionizing-CoronAry-sTentING
Данни: CORDIS, © Европейски съюз
